| 产品名称: | Streptomyces sparsogenes Owen et al. |
|---|---|
| 商品货号: | TS206930 |
| Strain Designations: | ISP 5356 CBS 672.69, CBS 958.69, IFO 13086, KCC S-0517, NCIB 9449, NRRL 2940; UC 2474, RIA 1278 |
| Application: | Produces sparsomycin |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | 2°C to 8°C |
| Preceptrol®: | no |
| Type Strain: | yes (type strain) |
| Comments: | Streptomyces violaceusniger |
| Medium: | ATCC® Medium 527: Inorganic salts starch agar (ISP Medium 4) |
| Growth Conditions: | Temperature: 26.0°C Atmosphere:xa0 Aerobicxa0 |
| Name of Depositor: | EB Shirling |
| Chain of Custody: | ATCC < |
| References: | Owen SP, et al. Sparsomycin, a new antitumor antibiotic. I. Discovery and biological properties. Antimicrob. Agents Chemother. 1962: 772-779, 1963. Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. IV. Species descriptions from the second, third and fourth studies. Int J Syst Bacteriol 19: 391-512, 1969. . . Bergeys Manual Syst. Bacteriol. 4: 2476, 1989. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. type strain type strain |